Loading…
Loading…
Dr. Dr. Jitendra Prasad Yadav • Consultant Neurologist & Emergency Neuromuscular Specialist • NMC 8029
Rapidly progressive weakness starting in legs after recent infection? You may have Guillain-Barré syndrome (GBS) — an acute autoimmune attack on peripheral nerves requiring urgent hospital care. Dr. Jitendra Prasad Yadav (NMC 8029), Consultant Neurologist with 15+ years at National Trauma Center (NAMS), provides GBS evaluation, IVIG coordination, and recovery monitoring at Kathmandu Neurology Clinic & Cognitive Center, Durbar Marg, Opposite of Yak & Yeti Hotel, Kathmandu.
Nepal Medical Council Reg. No. 8029 • 15+ years National Trauma Center, NAMS • Part of Clinics Tree Healthcare Network
What is Guillain-Barré Syndrome?
Guillain-Barré syndrome causes rapidly progressive weakness due to immune attack on peripheral nerves, with risk of respiratory failure requiring ICU care.
Guillain-Barré syndrome (GBS) is an acute autoimmune polyradiculoneuropathy — the immune system attacks peripheral nerve myelin (demyelinating form) or axons (axonal form), causing rapidly progressive ascending paralysis. Typical pattern: weakness begins in legs (difficulty standing, walking), ascends to arms, trunk, and potentially facial, swallowing, and respiratory muscles. Progression is rapid — weakness peaks within 2-4 weeks of onset.
GBS is a neurological emergency because 20-30% of patients develop respiratory failure requiring mechanical ventilation. Early recognition and hospital admission for monitoring and treatment (IVIG or plasmapheresis) improve outcomes.
GBS is triggered by preceding infection in ~70% of cases, typically 1-3 weeks before weakness onset:
Mechanism: Molecular mimicry — antibodies against infection cross-react with gangliosides (nerve membrane components), causing immune-mediated nerve damage. No preventive treatment exists.
Typical progression:
Key clinical features:
Clinical diagnosis: Acute progressive symmetric weakness with reduced/absent reflexes. History of preceding infection (1-3 weeks prior). No alternative explanation (stroke, spinal cord compression, myasthenia gravis, electrolyte disturbance).
Confirmatory tests:
Immunotherapy: Two equally effective options:
Corticosteroids are NOT effective in GBS and are not recommended.
Supportive care (critical):
IVIG availability: Available at major hospitals in Kathmandu (TUTH, NAMS, Bir Hospital, private hospitals with ICU). Cost is substantial (varies, typically NPR 100,000-300,000+ for full course depending on patient weight and IVIG brand), creating access barrier. Some health insurance covers IVIG; government support programs exist but have limited capacity.
Plasmapheresis: Limited availability — requires apheresis machine and trained operators. Available at select centers (TUTH, some private hospitals). Logistics and cost are challenges.
ICU capacity: Limited in Nepal. During peak seasons or outbreaks (e.g., Campylobacter outbreak), ICU bed availability may be constrained. Early recognition and admission planning are critical.
Dr. Jitendra coordinates with hospital neurology and ICU teams to facilitate GBS admission, IVIG access, and ongoing management for his patients.
Overall outcomes: 80% of GBS patients eventually walk independently. 20-30% have residual deficits (weakness, sensory loss, fatigue). Mortality 3-5% (respiratory failure, autonomic instability, infections, pulmonary embolism).
Recovery timeline: Weakness peaks at 2-4 weeks, plateau phase lasts days to weeks, then gradual recovery over 3-12 months (sometimes longer). Nerve regeneration is slow (~1 mm/day). Physiotherapy is essential during recovery.
Predictors of poor prognosis: Rapid progression (unable to walk within 7 days of onset), older age (>60 years), need for mechanical ventilation, severe axonal damage on NCS, preceding Campylobacter infection. These patients may have prolonged recovery (>1 year) and residual deficits.
Relapses: Rare (<5%). If weakness recurs or progresses after initial improvement, consider chronic inflammatory demyelinating polyneuropathy (CIDP) — a relapsing form requiring long-term immunotherapy.
Seek immediate hospital evaluation for: rapidly worsening weakness over days (unable to walk, stand from chair, lift arms), difficulty swallowing or choking on food, shortness of breath or rapid breathing, inability to take deep breath, facial weakness on both sides, severe back or limb pain with progressive weakness. These symptoms suggest GBS and require urgent hospital admission for monitoring and treatment.
Dr. Jitendra Prasad Yadav (NMC 8029), Consultant Neurologist with 15+ years at National Trauma Center (NAMS), provides:
For acute GBS with severe symptoms, proceed directly to hospital emergency department. For uncertain or early symptoms, call 974-7736624 for urgent consultation or book via /book-appointment.
Urgent GBS Consultation
Kathmandu Neurology Clinic & Cognitive Center
Durbar Marg, Opposite of Yak & Yeti Hotel, Kathmandu 44600, Nepal
Phone: 974-7736624 • +977 9747978200
Sun-Sat 9AM-7PM • By Appointment • Near Narayanhiti Palace Museum • 27.7172, 85.3240
Book Urgent GBS EvaluationRelated Emergency Neurology Pages
EMERGENCY WARNING
GBS is a neurological emergency. If you have rapidly progressive weakness, difficulty breathing/swallowing, or inability to walk, proceed IMMEDIATELY to hospital emergency department (TUTH, NAMS, or nearest ICU-capable hospital). Do not delay.
Page Information
Guillain-Barré syndrome is an acute autoimmune polyradiculoneuropathy where the immune system attacks peripheral nerve myelin and axons, causing rapidly progressive weakness ascending from legs to arms, trunk, and potentially respiratory muscles. Most cases follow infection (gastroenteritis, respiratory illness) by 1-3 weeks. Weakness peaks within 2-4 weeks, then plateaus. Recovery occurs over months via nerve regeneration, though 20-30% have residual deficits. GBS is a neurological emergency — respiratory failure requiring mechanical ventilation occurs in 20-30% of cases.
Progressive weakness starting in legs (difficulty walking, standing from chair), ascending to arms (hand weakness, trouble lifting arms), facial weakness (inability to smile, close eyes fully), difficulty swallowing or speaking, breathing difficulty. Sensory: tingling, numbness (usually less prominent than weakness), back/limb pain (50% of cases). Autonomic: blood pressure fluctuations, heart rate irregularities, urinary retention. Red flags: rapidly worsening weakness over days, shortness of breath, difficulty swallowing — these require emergency hospital evaluation for respiratory monitoring.
Clinical diagnosis based on acute progressive symmetric weakness with reduced/absent reflexes. Lumbar puncture shows elevated CSF protein with normal white blood cell count (albuminocytologic dissociation) — classic for GBS, though may be normal in first week. Nerve conduction studies show demyelinating or axonal patterns. Blood tests exclude mimics (potassium, magnesium, tick paralysis, botulism, myasthenia gravis). MRI spine with contrast may show nerve root enhancement. At Kathmandu Neurology Clinic, Dr. Jitendra Prasad Yadav (NMC 8029) performs initial evaluation and coordinates urgent hospital admission for confirmed or suspected GBS.
GBS is autoimmune, often triggered by preceding infection: Campylobacter jejuni gastroenteritis (most common, associated with worse prognosis), respiratory viruses (influenza, COVID-19, EBV, CMV), Zika virus, rarely vaccines. Infection triggers molecular mimicry — antibodies against infection cross-react with peripheral nerve components (gangliosides). No preventive treatment exists; vaccination benefits outweigh small GBS risk.
Treatment goal: reduce disease severity and hasten recovery. Two options: intravenous immunoglobulin (IVIG) 0.4g/kg daily × 5 days (first-line, requires hospital admission) or plasmapheresis (plasma exchange) — both equally effective. IVIG is more readily available in Kathmandu hospitals (TUTH, NAMS, private hospitals with ICU capability). Plasmapheresis requires specialized equipment, limited availability. Supportive care: respiratory monitoring (forced vital capacity measurements, intubation/ventilation if respiratory failure), DVT prophylaxis (anticoagulation — immobility increases clot risk), pain management (opioids, gabapentin), physical therapy during recovery. Corticosteroids are NOT effective in GBS.
Most patients recover, but timeline varies. Weakness peaks at 2-4 weeks, plateau phase lasts weeks, then gradual recovery over months (3-12 months typical). 80% eventually walk independently; 20-30% have residual deficits (weakness, sensory loss, fatigue). Mortality 3-5% (respiratory failure, autonomic instability, infections). Predictors of poor outcome: rapid progression, need for ventilation, severe axonal damage on NCS, older age, preceding Campylobacter infection. Early IVIG/plasmapheresis improves outcomes. Relapses are rare (<5%).
Seek emergency evaluation immediately if you experience: rapidly worsening weakness (unable to walk, stand, or lift arms within days), difficulty swallowing or choking on food, shortness of breath or rapid breathing, inability to take deep breath, facial weakness on both sides, severe back or limb pain with progressive weakness. GBS requires hospital admission for respiratory monitoring, IVIG, and supportive care — do not delay.
For suspected GBS, seek emergency care at hospital with ICU capability (TUTH, NAMS, Bir Hospital, private hospitals with neurology). Kathmandu Neurology Clinic & Cognitive Center (Dr. Jitendra Prasad Yadav, NMC 8029), Durbar Marg, Opposite of Yak & Yeti Hotel, provides: urgent outpatient evaluation for early/uncertain symptoms, coordination with hospital teams for admission and IVIG, post-hospital follow-up, nerve conduction studies interpretation, recovery monitoring, rehabilitation coordination. Call 974-7736624 for urgent consultation or proceed directly to hospital emergency if severe symptoms. Bring records of recent infections, vaccinations, medications.
Content on this website is for general educational purposes only and does not constitute medical advice, diagnosis, or treatment. It is not a substitute for evaluation by a qualified healthcare professional. Always seek the advice of your physician or other qualified provider with any questions regarding a medical condition. Never disregard professional medical advice or delay seeking it because of something you have read on this website. In case of a medical emergency, contact emergency services immediately. No doctor–patient relationship is established by use of this site or by contacting the clinic through the site.